The activation of CS is found in the pathophysiology of acute respiratory distress syndrome (ARDS) with increased levels of plasma complement-positive regulators, particularly higher expression levels of complement anaphylatoxins C5a and C3a that are the main mediators of PICyts (Vinciguerra et al., 2020). This evidence concerns the gene C3 and acute respiratory distress syndrome.